Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy.
Glutamate, aspartate and gamma-aminobutyrate (GABA) concentrations and choline acetyltransferase (ChAT) activity were measured in postmortem cerebellar cortical areas and brainstem nuclei of 10 normal controls, 5 patients of olivopontocerebellar atrophy (OPCA) with multiple system atrophy (MSA) and 2 patients of cortical cerebellar atrophy (CCA). In addition, the neuronal cell density in the cerebellar cortex and the brainstem nuclei was determined, and the correlation between neurotransmitter markers and the neuronal cell densities were investigated. Glutamate and aspartate concentrations in the cerebellar cortical tissues were markedly varied from case to case of MSA (OPCA) and CCA patients. However, glutamate concentration in the anterior vermis showed a positive correlation coefficient with the density of granule cells (r = 0.554, 0.05 less than P less than 0.10) and, those in the posterior vermis and in the cerebellar hemisphere were positively correlated with cells in the inferior olive (r = 0.707 and 0.607, P less than 0.05, respectively). Aspartate concentration in the anterior vermis also has a positive correlation coefficient (r = 0.571, 0.05 less than P less than 0.10) with the density of cells in the inferior olive. GABA concentrations in the dentate nucleus were decreased in all cases of MSA (OPCA) and CCA, and were positively correlated with the degree of loss of Purkinje cells (r = 0.765, P less than 0.01). ChAT activities were decreased in certain cases of MSA (OPCA), but conversely, increased in CCA patients. ChAT activity in the posterior vermis has a positive correlation coefficient (r = 0.613, 0.05 less than P0.10) with the cell density in the pontine nucleus. A possibility of a compensatory increase of ChAT activity in CCA patients was discussed.
Kanazawa
I
I
Kwak
S
S
Sasaki
H
H
Mizusawa
H
H
Muramoto
O
O
Yoshizawa
K
K
Nukina
N
N
Kitamura
K
K
Kurisaki
H
H
Sugita
K
K
D000328:Adult; D000368:Aged; D001224:Aspartic Acid / Q000032:analysis; D001933:Brain Stem / Q000032:analysis / Q000473:pathology; D002452:Cell Count; D002525:Cerebellar Cortex / Q000032:analysis* / Q000473:pathology; D002526:Cerebellar Diseases / Q000378:metabolism / Q000473:pathology*; D002795:Choline O-Acetyltransferase / Q000032:analysis; D005260:Female; D005971:Glutamates / Q000032:analysis; D018698:Glutamic Acid; D006801:Humans; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000032:analysis / Q000473:pathology*; D018377:Neurotransmitter Agents / Q000032:analysis*; D009847:Olivary Nucleus / Q000032:analysis / Q000473:pathology; D011149:Pons / Q000032:analysis / Q000473:pathology; D005680:gamma-Aminobutyric Acid / Q000032:analysis
D005971:Glutamates; D018377:Neurotransmitter Agents; D001224:Aspartic Acid; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D002795:Choline O-Acetyltransferase